Chlorine in PDB 6g07: Rorgt (264-518;C455S) in Complex with Inverse Agonist "Cpd-9" and RIP140 Peptide at 1.66A
Protein crystallography data
The structure of Rorgt (264-518;C455S) in Complex with Inverse Agonist "Cpd-9" and RIP140 Peptide at 1.66A, PDB code: 6g07
was solved by
J.Kallen,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
19.38 /
1.66
|
Space group
|
P 1 21 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
85.935,
68.058,
96.522,
90.00,
110.83,
90.00
|
R / Rfree (%)
|
21.4 /
23.3
|
Chlorine Binding Sites:
The binding sites of Chlorine atom in the Rorgt (264-518;C455S) in Complex with Inverse Agonist "Cpd-9" and RIP140 Peptide at 1.66A
(pdb code 6g07). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total 4 binding sites of Chlorine where determined in the
Rorgt (264-518;C455S) in Complex with Inverse Agonist "Cpd-9" and RIP140 Peptide at 1.66A, PDB code: 6g07:
Jump to Chlorine binding site number:
1;
2;
3;
4;
Chlorine binding site 1 out
of 4 in 6g07
Go back to
Chlorine Binding Sites List in 6g07
Chlorine binding site 1 out
of 4 in the Rorgt (264-518;C455S) in Complex with Inverse Agonist "Cpd-9" and RIP140 Peptide at 1.66A
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 1 of Rorgt (264-518;C455S) in Complex with Inverse Agonist "Cpd-9" and RIP140 Peptide at 1.66A within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl601
b:23.8
occ:1.00
|
CL8
|
A:EEZ601
|
0.0
|
23.8
|
1.0
|
C2
|
A:EEZ601
|
1.8
|
21.7
|
1.0
|
C1
|
A:EEZ601
|
2.7
|
20.6
|
1.0
|
C3
|
A:EEZ601
|
2.7
|
21.4
|
1.0
|
O7
|
A:EEZ601
|
3.0
|
22.5
|
1.0
|
O
|
A:CYS320
|
3.6
|
15.8
|
1.0
|
CB
|
A:CYS320
|
3.8
|
16.6
|
1.0
|
CA
|
A:CYS320
|
3.9
|
16.5
|
1.0
|
N4
|
A:EEZ601
|
4.0
|
20.4
|
1.0
|
C6
|
A:EEZ601
|
4.0
|
19.2
|
1.0
|
SG
|
A:CYS320
|
4.0
|
18.1
|
1.0
|
C
|
A:CYS320
|
4.2
|
16.1
|
1.0
|
CB
|
A:HIS323
|
4.3
|
15.8
|
1.0
|
CE1
|
A:PHE378
|
4.4
|
16.5
|
1.0
|
C10
|
A:EEZ601
|
4.4
|
23.8
|
1.0
|
C5
|
A:EEZ601
|
4.5
|
19.5
|
1.0
|
N
|
A:LEU324
|
4.6
|
15.7
|
1.0
|
CD1
|
A:PHE378
|
4.8
|
16.9
|
1.0
|
CB
|
A:LEU324
|
4.8
|
16.6
|
1.0
|
C12
|
A:EEZ601
|
4.8
|
24.8
|
1.0
|
|
Chlorine binding site 2 out
of 4 in 6g07
Go back to
Chlorine Binding Sites List in 6g07
Chlorine binding site 2 out
of 4 in the Rorgt (264-518;C455S) in Complex with Inverse Agonist "Cpd-9" and RIP140 Peptide at 1.66A
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 2 of Rorgt (264-518;C455S) in Complex with Inverse Agonist "Cpd-9" and RIP140 Peptide at 1.66A within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Cl601
b:23.1
occ:1.00
|
CL8
|
B:EEZ601
|
0.0
|
23.1
|
1.0
|
C2
|
B:EEZ601
|
1.7
|
19.6
|
1.0
|
C3
|
B:EEZ601
|
2.7
|
19.4
|
1.0
|
C1
|
B:EEZ601
|
2.7
|
19.0
|
1.0
|
O7
|
B:EEZ601
|
3.0
|
20.2
|
1.0
|
CD2
|
B:LEU324
|
3.6
|
16.3
|
0.5
|
CG
|
B:LEU324
|
3.7
|
15.8
|
0.5
|
CB
|
B:CYS320
|
3.7
|
16.7
|
1.0
|
O
|
B:CYS320
|
3.8
|
17.0
|
1.0
|
SG
|
B:CYS320
|
3.8
|
18.1
|
1.0
|
CA
|
B:CYS320
|
3.9
|
16.7
|
1.0
|
N4
|
B:EEZ601
|
4.0
|
18.1
|
1.0
|
C6
|
B:EEZ601
|
4.0
|
17.8
|
1.0
|
C
|
B:CYS320
|
4.2
|
16.7
|
1.0
|
CE1
|
B:PHE378
|
4.2
|
13.2
|
1.0
|
CD1
|
B:LEU324
|
4.3
|
18.0
|
0.5
|
CD1
|
B:LEU324
|
4.3
|
15.8
|
0.5
|
C10
|
B:EEZ601
|
4.4
|
20.8
|
1.0
|
CB
|
B:HIS323
|
4.4
|
16.0
|
1.0
|
C5
|
B:EEZ601
|
4.5
|
17.7
|
1.0
|
CD1
|
B:PHE378
|
4.6
|
14.4
|
1.0
|
N
|
B:LEU324
|
4.7
|
16.0
|
1.0
|
CE1
|
B:PHE388
|
4.8
|
18.6
|
1.0
|
C12
|
B:EEZ601
|
4.8
|
21.3
|
1.0
|
CB
|
B:LEU324
|
4.9
|
15.9
|
0.5
|
CB
|
B:LEU324
|
4.9
|
16.2
|
0.5
|
|
Chlorine binding site 3 out
of 4 in 6g07
Go back to
Chlorine Binding Sites List in 6g07
Chlorine binding site 3 out
of 4 in the Rorgt (264-518;C455S) in Complex with Inverse Agonist "Cpd-9" and RIP140 Peptide at 1.66A
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 3 of Rorgt (264-518;C455S) in Complex with Inverse Agonist "Cpd-9" and RIP140 Peptide at 1.66A within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Cl601
b:23.5
occ:1.00
|
CL8
|
C:EEZ601
|
0.0
|
23.5
|
1.0
|
C2
|
C:EEZ601
|
1.7
|
21.1
|
1.0
|
C3
|
C:EEZ601
|
2.7
|
21.7
|
1.0
|
C1
|
C:EEZ601
|
2.7
|
20.3
|
1.0
|
O7
|
C:EEZ601
|
3.0
|
22.3
|
1.0
|
CG
|
C:LEU324
|
3.7
|
16.8
|
0.5
|
CD2
|
C:LEU324
|
3.7
|
17.3
|
0.5
|
O
|
C:CYS320
|
3.7
|
16.2
|
1.0
|
CB
|
C:CYS320
|
3.8
|
16.7
|
1.0
|
CA
|
C:CYS320
|
3.9
|
16.7
|
1.0
|
N4
|
C:EEZ601
|
4.0
|
20.6
|
1.0
|
SG
|
C:CYS320
|
4.0
|
18.1
|
1.0
|
C6
|
C:EEZ601
|
4.0
|
19.1
|
1.0
|
C
|
C:CYS320
|
4.3
|
16.3
|
1.0
|
CD1
|
C:LEU324
|
4.4
|
16.9
|
0.5
|
CB
|
C:HIS323
|
4.4
|
16.3
|
1.0
|
CE1
|
C:PHE378
|
4.4
|
17.1
|
1.0
|
C10
|
C:EEZ601
|
4.4
|
23.4
|
1.0
|
C5
|
C:EEZ601
|
4.5
|
19.5
|
1.0
|
N
|
C:LEU324
|
4.6
|
16.6
|
1.0
|
CD1
|
C:PHE378
|
4.7
|
17.7
|
1.0
|
CD1
|
C:LEU324
|
4.7
|
18.6
|
0.5
|
C12
|
C:EEZ601
|
4.7
|
24.8
|
1.0
|
CB
|
C:LEU324
|
4.8
|
16.8
|
0.5
|
CB
|
C:LEU324
|
4.9
|
17.2
|
0.5
|
C11
|
C:EEZ601
|
5.0
|
23.8
|
1.0
|
|
Chlorine binding site 4 out
of 4 in 6g07
Go back to
Chlorine Binding Sites List in 6g07
Chlorine binding site 4 out
of 4 in the Rorgt (264-518;C455S) in Complex with Inverse Agonist "Cpd-9" and RIP140 Peptide at 1.66A
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 4 of Rorgt (264-518;C455S) in Complex with Inverse Agonist "Cpd-9" and RIP140 Peptide at 1.66A within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:Cl601
b:24.5
occ:1.00
|
CL8
|
D:EEZ601
|
0.0
|
24.5
|
1.0
|
C2
|
D:EEZ601
|
1.8
|
21.9
|
1.0
|
C3
|
D:EEZ601
|
2.7
|
22.1
|
1.0
|
C1
|
D:EEZ601
|
2.7
|
20.9
|
1.0
|
O7
|
D:EEZ601
|
3.0
|
22.8
|
1.0
|
CG
|
D:LEU324
|
3.6
|
15.1
|
0.5
|
O
|
D:CYS320
|
3.7
|
15.3
|
1.0
|
CB
|
D:CYS320
|
3.8
|
15.2
|
1.0
|
CD2
|
D:LEU324
|
3.9
|
15.3
|
0.5
|
CA
|
D:CYS320
|
4.0
|
15.4
|
1.0
|
N4
|
D:EEZ601
|
4.0
|
20.5
|
1.0
|
C6
|
D:EEZ601
|
4.0
|
20.0
|
1.0
|
SG
|
D:CYS320
|
4.1
|
17.1
|
1.0
|
CD1
|
D:LEU324
|
4.2
|
15.6
|
0.5
|
C
|
D:CYS320
|
4.3
|
15.1
|
1.0
|
CB
|
D:HIS323
|
4.3
|
14.3
|
1.0
|
C10
|
D:EEZ601
|
4.4
|
23.6
|
1.0
|
CE1
|
D:PHE378
|
4.4
|
14.1
|
1.0
|
C5
|
D:EEZ601
|
4.5
|
20.7
|
1.0
|
N
|
D:LEU324
|
4.5
|
14.8
|
1.0
|
CD1
|
D:PHE378
|
4.7
|
15.1
|
1.0
|
CB
|
D:LEU324
|
4.8
|
14.9
|
0.5
|
C12
|
D:EEZ601
|
4.8
|
24.4
|
1.0
|
CB
|
D:LEU324
|
4.8
|
15.0
|
0.5
|
CA
|
D:LEU324
|
5.0
|
14.9
|
0.5
|
CA
|
D:LEU324
|
5.0
|
15.0
|
0.5
|
|
Reference:
D.A.Carcache,
A.Vulpetti,
J.Kallen,
H.Mattes,
D.Orain,
R.Stringer,
E.Vangrevelinghe,
R.M.Wolf,
K.Kaupmann,
J.Ottl,
J.Dawson,
N.G.Cooke,
K.Hoegenauer,
A.Billich,
J.Wagner,
C.Guntermann,
S.Hintermann.
Optimizing A Weakly Binding Fragment Into A Potent Ror Gamma T Inverse Agonist with Efficacy in An in Vivo Inflammation Model. J. Med. Chem. V. 61 6724 2018.
ISSN: ISSN 1520-4804
PubMed: 29990434
DOI: 10.1021/ACS.JMEDCHEM.8B00529
Page generated: Sat Jul 27 23:37:41 2024
|